Collegium Pharma (COLL) Stock Price, Quote & News

Company Profile

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-dete...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 781 713 3699

Website: www.collegiumpharma.com

Address:

100 Technology Center Drive, Suite 300, Stoughton, United States

jewell69 Jun. 6 at 4:34 PM

$COLL got opium ? (a spoof on tv ads, got milk) took profits, but all $IBB $XBI is (APPARENTLY) up today 6/6/25 tryin 2 sell $FRSH 15.72 now b a .63 x .64 12:31 pm EDT

0 · Reply

jewell69 Jun. 3 at 5:47 PM

$COLL TRYIN 2 ChASE/ BUY 29.27 LAST TIME WE TOOK PROFITS WAS B4 NICE EARNIN ON 5/8/25 STOCK IS UP SINCE 5/8, BUT 10 DAY gRAPh IS DOWN 2 EYE LAShES Symbol description COLLEGIUM PHARMACEUTICAL INC COM Type Cash Shares -222.000 Price $27.14 Amount $6,023.80 Fees $0.17 Settlement date Apr-29-2025

0 · Reply

jewell69 May. 15 at 12:39 AM

$COLL PAIN MEDICINE, seriously. I like 2 joke got opium ? reminds me of Sean Penn / Madonna movie 1986 Shanghai Surprise - takes place in occupied China $MCHI (occupied by $EWJ Japan in 1936) movie starts w/ just SOME of China occupied; but another huge swath of land is imminently being taken over. Opium kingpin tries to move 1100 pounds of opium to safer, quieter remaining $MCHI land. But, Madonna wants all of it.

0 · Reply

jewell69 May. 15 at 12:32 AM

$COLL 5/14 CLOSE 29.07 -2.45% TODAY !! 05/13/2025 Sell Trade Details COLL COLLEGIUM PHARMACEUTICAL 60 $29.779 $0.01 $1,786.73 04/01/2025 Buy Trade Details COLL COLLEGIUM PHARMACEUTICAL 60 $29.55 -$1,773.00 01/07/2025 Sell Trade Details COLL COLLEGIUM PHARMACEUTICAL 200 $29.12 $0.19 $5,823.81 01/06/2025 Buy Trade Details COLL COLLEGIUM PHARMACEUTICAL 200 $28.62 -$5,724.00

0 · Reply

jewell69 May. 10 at 8:18 PM

$COLL after close on 5/8 Reports Q1 (Mar) earnings of $1.49 per share, excluding non-recurring items, $0.06 better than the FactSet Consensus of $1.43; revenues rose 22.7% year/year to $177.76 mln vs the $171.95 mln FactSet Consensus. Co reaffirms guidance for FY25, sees FY25 revs of $735-$750 mln vs. $741.47 mln FactSet Consensus 5/9 up 5.94% to 28.89 too bad I paid 29.55 on 4/1 (b4 all _ell broke loose on 4/7 or 4/9 = bottom of market, remember )

0 · Reply

JarvisFlow May. 9 at 2:34 PM

Piper Sandler has updated their rating for Collegium Pharmaceutical ( $COLL ) to Neutral with a price target of 37.

0 · Reply

Estimize May. 8 at 3:13 PM

Wall St is expecting 1.61 EPS for $COLL Q2 [Reporting 07/31 AMC] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co

0 · Reply

Estimize May. 6 at 12:24 PM

Wall St is expecting 1.43 EPS for $COLL Q1 [Reporting 05/08 AMC] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co

0 · Reply

jewell69 Apr. 28 at 2:42 PM

$COLL sold just now 4/28 11:39 am EDT Type Cash Shares -222.000 Price $27.14 Amount $6,023.80 Fees $0.17 Settlement date Apr-29-2025 BOT 4/23 Type Cash Shares +222.000 Price $26.23 Amount -$5,823.06 Settlement date Apr-24-2025

0 · Reply

Stockpsych11 Apr. 27 at 7:41 PM

$COLL like this pick long term.

0 · Reply

Collegium Pharmaceutical: Stock Deserves A "Buy" Call On Undervaluation Of ADHD Drug

May 19, 2025, 4:01 PM EDT - 6 weeks ago

Collegium to Participate in Upcoming Investor Conferences

May 12, 2025, 8:05 AM EDT - 7 weeks ago

Collegium Announces $25 Million Accelerated Share Repurchase Program

May 9, 2025, 2:04 AM EDT - 7 weeks ago

Collegium Pharmaceutical, Inc. (COLL) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:01 PM EDT - 7 weeks ago

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

Apr 24, 2025, 8:00 AM EDT - 2 months ago

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 1, 2025, 8:00 AM EDT - 3 months ago

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Mar 27, 2025, 8:00 AM EDT - 3 months ago

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting

Mar 17, 2025, 7:00 AM EDT - 3 months ago

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

Mar 10, 2025, 6:57 PM EDT - 4 months ago

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Mar 9, 2025, 4:07 AM EDT - 4 months ago

Collegium Pharmaceutical's Shareholders Might Be In For A Pain-Free 2025

Feb 27, 2025, 9:03 PM EST - 4 months ago

Collegium Pharmaceutical, Inc. (COLL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:01 PM EST - 4 months ago

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Feb 13, 2025, 8:00 AM EST - 4 months ago

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Jan 8, 2025, 8:00 AM EST - 6 months ago

Collegium Provides 2025 Financial Guidance and Business Update

Nov 26, 2024, 8:00 AM EST - 7 months ago

Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion

Nov 14, 2024, 4:30 PM EST - 8 months ago

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)

Nov 8, 2024, 12:30 AM EST - 8 months ago

Collegium Pharmaceutical, Inc. (COLL) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:02 PM EST - 8 months ago

Collegium Reports Record Third Quarter 2024 Financial Results

Aug 30, 2024, 8:00 AM EDT - 10 months ago

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 8, 2024, 9:30 PM EDT - 11 months ago

Collegium Pharmaceutical, Inc. (COLL) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 11 months ago

Collegium Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 6:00 AM EDT - 1 year ago

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

May 29, 2024, 8:00 AM EDT - 1 year ago

Collegium to Participate in Jefferies Global Healthcare Conference

May 13, 2024, 8:00 AM EDT - 1 year ago

Collegium Announces $35 Million Accelerated Share Repurchase Program

May 9, 2024, 7:32 PM EDT - 1 year ago

Collegium Pharmaceutical, Inc. (COLL) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:02 PM EDT - 1 year ago

Collegium Reports First Quarter 2024 Financial Results

Apr 25, 2024, 8:00 AM EDT - 1 year ago

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Apr 11, 2024, 8:00 AM EDT - 1 year ago

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

Mar 12, 2024, 5:00 AM EDT - 1 year ago

Top 10 Small-Cap Stocks (SA Quant)

ANIP APOG BASE BLBD GCT PLMR RAMP

Feb 22, 2024, 9:52 PM EST - 1 year ago

Collegium Pharmaceutical's (COLL) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 4:09 PM EST - 1 year ago

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

Feb 8, 2024, 8:00 AM EST - 1 year ago

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

Nov 27, 2023, 8:00 AM EST - 1 year ago

Appeals Court Upholds PTAB's Finding of Invalidity of Purdue's 961 Patent

Nov 7, 2023, 10:15 PM EST - 1 year ago

Collegium Pharmaceutical, Inc. (COLL) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:01 PM EST - 1 year ago

Collegium Reports Third Quarter 2023 Financial Results

Oct 24, 2023, 2:59 PM EDT - 1 year ago

Collegium Pharmaceutical: Delivering On Promises

Oct 24, 2023, 8:00 AM EDT - 1 year ago

Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023

Aug 28, 2023, 8:00 AM EDT - 2 years ago

Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023

Aug 24, 2023, 8:00 AM EDT - 2 years ago

Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026

Aug 12, 2023, 5:25 AM EDT - 2 years ago

Collegium Pharmaceutical: Pipeline Continues As Share Buyback Initiates

Aug 11, 2023, 11:20 AM EDT - 2 years ago

With 30% Returns On Capital Deployed At 4.4x Earnings, Collegium Is A Buy

Aug 7, 2023, 7:30 AM EDT - 2 years ago

Collegium Announces $50 Million Accelerated Share Repurchase Program

Aug 4, 2023, 4:50 PM EDT - 2 years ago

Collegium Pharmaceutical, Inc. (COLL) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 4:01 PM EDT - 2 years ago

Collegium Reports Record 1H'23 Net Revenue of $280.3 Million, Up 35% Year-over-Year

Jul 20, 2023, 8:00 AM EDT - 2 years ago

Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023

Jun 1, 2023, 8:00 AM EDT - 2 years ago

Collegium to Participate in Jefferies Healthcare Conference

May 25, 2023, 8:14 AM EDT - 2 years ago

Collegium: Turning More Constructive, Especially At 4.4x Earnings

May 6, 2023, 10:16 PM EDT - 2 years ago

Collegium Pharmaceutical, Inc. (COLL) Q1 2023 Earnings Call Transcript

May 4, 2023, 4:01 PM EDT - 2 years ago

Collegium Reports First Quarter 2023 Financial Results

jewell69 Jun. 6 at 4:34 PM

$COLL got opium ? (a spoof on tv ads, got milk) took profits, but all $IBB $XBI is (APPARENTLY) up today 6/6/25 tryin 2 sell $FRSH 15.72 now b a .63 x .64 12:31 pm EDT

0 · Reply

jewell69 Jun. 3 at 5:47 PM

0 · Reply

jewell69 May. 15 at 12:39 AM

0 · Reply

jewell69 May. 15 at 12:32 AM

0 · Reply

jewell69 May. 10 at 8:18 PM

0 · Reply

JarvisFlow May. 9 at 2:34 PM

Piper Sandler has updated their rating for Collegium Pharmaceutical ( $COLL ) to Neutral with a price target of 37.

0 · Reply

Estimize May. 8 at 3:13 PM

Wall St is expecting 1.61 EPS for $COLL Q2 [Reporting 07/31 AMC] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co

0 · Reply

Estimize May. 6 at 12:24 PM

Wall St is expecting 1.43 EPS for $COLL Q1 [Reporting 05/08 AMC] http://www.estimize.com/intro/coll?chart=historical&metric_name=eps&utm_co

0 · Reply

jewell69 Apr. 28 at 2:42 PM

0 · Reply

Stockpsych11 Apr. 27 at 7:41 PM

$COLL like this pick long term.

0 · Reply

KissMyAngus02 Apr. 10 at 6:23 PM

$COLL anyone know why this has been so crushed? it's trading at a 13 P/E.

1 · Reply

JarvisFlow Apr. 9 at 1:00 PM

Needham has adjusted their stance on Collegium Pharmaceutical ( $COLL ), setting the rating to Buy with a target price of 46.

0 · Reply

JarvisFlow Mar. 24 at 12:30 PM

HC Wainwright & Co. updates rating for Collegium Pharmaceutical ( $COLL ) to Buy, target set at 50.

1 · Reply

dachshund36 Mar. 23 at 5:55 PM

$COLL Does anyone here have experience with Collegium's drugs? Especially wondering about sentiment on Journay. If you needed an ADHD medication for yourself or your family, would you pick this one?

1 · Reply

NVDAMillionaire Mar. 22 at 12:59 AM

$COLL Digging COLL's strategic moves in pain management and neuropsychiatry. Jornay PM looks promising. Adding to watchlist for potential entry point. insightful article: https://beyondspx.com/article/collegium-pharmaceutical-inc-coll-a-diversified-biopharmaceutical-leader-navigating-growth-and-innovation

0 · Reply

Thestocktraderhubzee Mar. 11 at 10:03 AM

WATCHLIST MAR 11 2025 $ASML ASML And imec Sign Five-Year Strategic Partnership To Advance Semiconductor R&D And Drive Sustainable Innovation Across Europe $COLL Reported Earlier, Collegium Highlights ADHD Therapy Advances With Jornay PM Posters At 2025 NAPNAP Pediatric Conference $AMD AMD Launches 5th Gen AMD EPYC Embedded Processors For Networking, Storage, And Industrial Edge Markets $TER Teradyne Division Mobile Industrial Robots Launches MiR VDA 5050 Adapter To Support Interoperability For Warehouses, Distribution Centers And Manufacturing Facilities $BTC Bitcoin, Ethereum, Dogecoin Sink Deeper As Recession Worries Overshadow Crypto Market: Arthur Hayes Has This Advice For Risk-Averse Traders

0 · Reply

Stefan100 Mar. 10 at 11:46 AM

$COLL enjoy my research https://seekingalpha.com/article/4765962-collegium-pharmaceuticals-shareholders-might-be-in-for-a-pain-free-2025

1 · Reply

isonize Mar. 7 at 12:48 AM

$COLL cheap stock !

0 · Reply

jewell69 Mar. 1 at 8:26 PM

$COLL too difficult now 2 make money reason $VRTX WASHINGTON (AP) 1/31/2025 — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter but I still need 2 study more

0 · Reply

jewell69 Feb. 28 at 3:24 PM

$COLL 10:26 am est 29.76 my after hours sale at 30.26 appears, for now, decent + Indeed, I could have gotten something like 30.76 in regular trading today. The stock appeared 5 - 6 weeks ago to start trading crummy after some other company came out with a non-addictive pain pill. I forgot who. It might be $VRTX I need to study

1 · Reply

jewell69 Feb. 28 at 1:44 PM

$COLL 8:42 am est 2/28 Schwab site showing last trade 28.60 Not sure if this is the Thursday 2/27 4 pm est close … or the premarket 2/28 Nevertheless I got out 2/27 late trading 30.26

0 · Reply

jewell69 Feb. 28 at 4:47 AM

2/27 Thursday after hours sale 30.26 Schwab had justreported30.20 as the last trade It was up about 6.5% in the after hours. W/o knowing any of the other after hours trade prices ( think or swim was frozen ) I just placed a limit to sell 177 $COLL at 30.26 and it immediately filled

0 · Reply

Market Cap	961.71M
Revenue (ttm)	631.45M
Net Income (ttm)	69.19M
EPS (ttm)	N/A
PE Ratio	5.18
Forward PE	4.89
Profit Margin	10.96%
Debt to Equity Ratio	2.56

Volume	271,000
Avg Vol	297,632
Day's Range	N/A - N/A
Shares Out	32.13M
Stochastic %K	39%
Beta	0.63
Analysts	Strong Sell
Price Target	$43.00